Myocardial scarring may be prognostic of ventricular arrhythmia risk among male endurance athletes who compete in events such as cycling and triathlons, according to data published in Circulation: Cardiovascular Imaging. Peter P. Swoboda, PhD, associate professor in cardiology of the Leeds Institute of Cardiovascular and Metabolic Medicine at the University of Leeds, U.K., and colleagues
The latest news from the ENDO Annual Meeting, with physician perspective, researcher interviews and clinician insight on diabetes, thyroid and other endocrine disorders.
In this video, Jeff Yu, MD, MS, highlighted the possible future directions of atopic dermatitis like further development of topical therapies, combination therapies and discussions of disease…
Myocardial scarring may be prognostic of ventricular arrhythmia risk among male endurance athletes who compete in events such as cycling and triathlons, according to data…
Drinking coffee may provide anti-inflammatory benefits leading to potential reductions in future risk for heart disease, according to a state-of-the-art review published in the European…
Patients who receive avacopan for antineutrophil cytoplasmic antibody-associated vasculitis demonstrate fewer infections and serious adverse events vs. non-avacopan treatment, according to a post-hoc analysis of…
SAN FRANCISCO — More women vs. men veterans with COPD received spirometry and tobacco cessation interventions, but more men received correct maintenance inhaler therapy, according…
SAN FRANCISCO — The menopause transition offers a valuable opportunity to forecast a woman’s health risks, but clinicians should also prepare to educate patients on…
The triangular fibrocartilage complex is a critical structure in the wrist that provides stability to the distal radioulnar joint.Injury to the foveal attachment of the…
The FDA issued a complete response letter to Genentech indicating it cannot approve the company’s biologic license application seeking approval for glofitamab-gxbm as a treatment…
Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and health care professionals.
